The list of activities our smartphones can control grows daily. Transfer money? It’s simple. Order groceries? That, too. Turn off the bedroom lights? Check.
How about contraception?
Advancing new forms of birth control is a central focus at Daré Bioscience (NASDAQ: DARE), a San Diego-based biopharma company that’s built a pipeline of experimental devices and treatments tailored for women’s health.
This week it announced plans to add another contraceptive contender to its lineup with an agreement to acquire Microchips Biotech, an MIT spinout that—with the backing of the Bill & Melinda Gates Foundation and others—has been working to design an… Read more »
UNDERWRITERS AND PARTNERS
